BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

440 related articles for article (PubMed ID: 31046485)

  • 1. Circulating cell-free nucleic acids as biomarkers in colorectal cancer screening and diagnosis - an update.
    Molnár B; Galamb O; Kalmár A; Barták BK; Nagy ZB; Tóth K; Tulassay Z; Igaz P; Dank M
    Expert Rev Mol Diagn; 2019 Jun; 19(6):477-498. PubMed ID: 31046485
    [No Abstract]   [Full Text] [Related]  

  • 2. Circulating cell-free nucleic acids as biomarkers in colorectal cancer screening and diagnosis.
    Tóth K; Barták BK; Tulassay Z; Molnár B
    Expert Rev Mol Diagn; 2016; 16(2):239-52. PubMed ID: 26652067
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Cell-Free DNA as a Diagnostic Blood-Based Biomarker for Colorectal Cancer: A Systematic Review.
    Petit J; Carroll G; Gould T; Pockney P; Dun M; Scott RJ
    J Surg Res; 2019 Apr; 236():184-197. PubMed ID: 30694754
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Characteristics and diagnostic applications of circulating cell-free DNA in colorectal cancer].
    Barták BK; Márkus E; Kalmár A; Galamb O; Szigeti K; Nagy ZB; Zsigrai S; Tulassay Z; Dank M; Igaz P; Molnár B
    Orv Hetil; 2019 Jul; 160(30):1167-1177. PubMed ID: 31327245
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Blood Collection and Cell-Free DNA Isolation Methods Influence the Sensitivity of Liquid Biopsy Analysis for Colorectal Cancer Detection.
    Barták BK; Kalmár A; Galamb O; Wichmann B; Nagy ZB; Tulassay Z; Dank M; Igaz P; Molnár B
    Pathol Oncol Res; 2019 Jul; 25(3):915-923. PubMed ID: 29374860
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Somatic copy number alteration and fragmentation analysis in circulating tumor DNA for cancer screening and treatment monitoring in colorectal cancer patients.
    Hallermayr A; Wohlfrom T; Steinke-Lange V; Benet-Pagès A; Scharf F; Heitzer E; Mansmann U; Haberl C; de Wit M; Vogelsang H; Rentsch M; Holinski-Feder E; Pickl JMA
    J Hematol Oncol; 2022 Sep; 15(1):125. PubMed ID: 36056434
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Cell-Free DNA in Metastatic Colorectal Cancer: A Systematic Review and Meta-Analysis.
    Spindler KG; Boysen AK; Pallisgård N; Johansen JS; Tabernero J; Sørensen MM; Jensen BV; Hansen TF; Sefrioui D; Andersen RF; Brandslund I; Jakobsen A
    Oncologist; 2017 Sep; 22(9):1049-1055. PubMed ID: 28778958
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Circulating tumor DNA methylation profiles enable early diagnosis, prognosis prediction, and screening for colorectal cancer.
    Luo H; Zhao Q; Wei W; Zheng L; Yi S; Li G; Wang W; Sheng H; Pu H; Mo H; Zuo Z; Liu Z; Li C; Xie C; Zeng Z; Li W; Hao X; Liu Y; Cao S; Liu W; Gibson S; Zhang K; Xu G; Xu RH
    Sci Transl Med; 2020 Jan; 12(524):. PubMed ID: 31894106
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The diagnostic accuracy of circulating free DNA for the detection of KRAS mutation status in colorectal cancer: A meta-analysis.
    Xie W; Xie L; Song X
    Cancer Med; 2019 Mar; 8(3):1218-1231. PubMed ID: 30791218
    [TBL] [Abstract][Full Text] [Related]  

  • 10. A novel xenonucleic acid-mediated molecular clamping technology for early colorectal cancer screening.
    Sun Q; Pastor L; Du J; Powell MJ; Zhang A; Bodmer W; Wu J; Zheng S; Sha MY
    PLoS One; 2021; 16(10):e0244332. PubMed ID: 34610014
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Circulating biomarkers for early detection and clinical management of colorectal cancer.
    Marcuello M; Vymetalkova V; Neves RPL; Duran-Sanchon S; Vedeld HM; Tham E; van Dalum G; Flügen G; Garcia-Barberan V; Fijneman RJ; Castells A; Vodicka P; Lind GE; Stoecklein NH; Heitzer E; Gironella M
    Mol Aspects Med; 2019 Oct; 69():107-122. PubMed ID: 31189073
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Review of Blood-Based Colorectal Cancer Screening: How Far Are Circulating Cell-Free DNA Methylation Markers From Clinical Implementation?
    Worm Ørntoft MB
    Clin Colorectal Cancer; 2018 Jun; 17(2):e415-e433. PubMed ID: 29678513
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Novel DNA methylation biomarkers show high sensitivity and specificity for blood-based detection of colorectal cancer-a clinical biomarker discovery and validation study.
    Jensen SØ; Øgaard N; Ørntoft MW; Rasmussen MH; Bramsen JB; Kristensen H; Mouritzen P; Madsen MR; Madsen AH; Sunesen KG; Iversen LH; Laurberg S; Christensen IJ; Nielsen HJ; Andersen CL
    Clin Epigenetics; 2019 Nov; 11(1):158. PubMed ID: 31727158
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Systematic review of blood diagnostic markers in colorectal cancer.
    Nikolaou S; Qiu S; Fiorentino F; Rasheed S; Tekkis P; Kontovounisios C
    Tech Coloproctol; 2018 Jul; 22(7):481-498. PubMed ID: 30022330
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Serum methylation of GALNT9, UPF3A, WARS, and LDB2 as noninvasive biomarkers for the early detection of colorectal cancer and advanced adenomas.
    Gallardo-Gómez M; Rodríguez-Girondo M; Planell N; Moran S; Bujanda L; Etxart A; Castells A; Balaguer F; Jover R; Esteller M; Cubiella J; Gómez-Cabrero D; De Chiara L
    Clin Epigenetics; 2023 Oct; 15(1):157. PubMed ID: 37794510
    [TBL] [Abstract][Full Text] [Related]  

  • 16. A new approach to epigenome-wide discovery of non-invasive methylation biomarkers for colorectal cancer screening in circulating cell-free DNA using pooled samples.
    Gallardo-Gómez M; Moran S; Páez de la Cadena M; Martínez-Zorzano VS; Rodríguez-Berrocal FJ; Rodríguez-Girondo M; Esteller M; Cubiella J; Bujanda L; Castells A; Balaguer F; Jover R; De Chiara L
    Clin Epigenetics; 2018; 10():53. PubMed ID: 29686738
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Diagnostic and prognostic role of cell-free DNA testing for colorectal cancer patients.
    Bedin C; Enzo MV; Del Bianco P; Pucciarelli S; Nitti D; Agostini M
    Int J Cancer; 2017 Apr; 140(8):1888-1898. PubMed ID: 27943272
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Circadian Rhythm of Methylated Septin 9, Cell-Free DNA Amount and Tumor Markers in Colorectal Cancer Patients.
    Tóth K; Patai ÁV; Kalmár A; Barták BK; Nagy ZB; Galamb O; Wichmann B; Tulassay Z; Molnár B
    Pathol Oncol Res; 2017 Jul; 23(3):699-706. PubMed ID: 28035516
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Role of miRNA-210, miRNA-21 and miRNA-126 as diagnostic biomarkers in colorectal carcinoma: impact of HIF-1α-VEGF signaling pathway.
    Sabry D; El-Deek SEM; Maher M; El-Baz MAH; El-Bader HM; Amer E; Hassan EA; Fathy W; El-Deek HEM
    Mol Cell Biochem; 2019 Apr; 454(1-2):177-189. PubMed ID: 30357530
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The role of
    Sun J; Fei F; Zhang M; Li Y; Zhang X; Zhu S; Zhang S
    BMC Cancer; 2019 May; 19(1):450. PubMed ID: 31088406
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 22.